Indian generics would soon become the backbone of the global HIV response. Within two years, the US launched PEPFAR, the ...

FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.

See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

Q3 2025 Earnings Call Transcript November 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...

A molecular switch in breast cancer cells reprograms the genetic production line towards tumor growth and stress resistance.

The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...

Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.

This case study demonstrates how advanced NMR spectroscopy enables high-resolution structural characterization of exenatide.

The European Commission’s plan to use joint procurement to provide access to innovative drugs across the bloc risks overuse of this process and could drown out competition, according to David Elvira, ...

Q3 2025 Earnings Call November 17, 2025 8:30 AM ESTCompany ParticipantsMatthew Duffy - Chief Business Officer & ...

NRx has refiled its Abbreviated New Drug Application for KETAFREE™ (preservative free ketamine), received supportive ...